Tag Archives: Foreign Corrupt Practices Act

How Pro-Active is Your Anti-Bribery Strategy?

How Pro-active is Your Anti-Bribery Strategy? Most multinationals are already familiar with the Foreign Corrupt Practices Act (FCPA). US regulators have been aggressively prosecuting companies and individuals for bribery with increasing zeal for the past decade, with healthcare companies being specially targeted. Recently, leading manufacturers of orthopedic implants: Zimmer, Depuy, Smith & Nephew, Biomet and […]
Posted in Guest Blog, Strategy | Also tagged , , , , | Leave a comment

Compliance and Reporting: The Case for a Single System

by James Pierce Pharmaceutical companies are awash in a sea of compliance regulations that affect their business operations both inside and outside the US. This August, one more compliance wave will crest when the Physician Payments Sunshine Act (PPSA) begins requiring pharmaceutical companies to track and report virtually all payments to health care providers (HCPs). […]
Posted in compliance, Corporate Responsibility, E-Media, Europe, FDA, Global, Guest Blog, Marketing, Regulatory, social media, Strategy, Technology | Also tagged , , , , , , | Leave a comment
  • Categories

  • Meta